Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’-Reference-Cited by-同舟云学术

Correspondence on ‘Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’

Published:2021-06-10 Issue:10 Volume:80 Page:e160-e160
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Veenstra Jesse^ORCID,Wang Jie,McKinnon-Maksimowicz Kathleen,Liu Tingting,Zuniga Bobby,Hamzavi Iltefat,Zhou Li,Mi Qing-Sheng^ORCID

Funder

NIH/NIAMS

Henry Ford Immunology Program

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference5 articles.

1. AB0540 COMPARISON OF EQ-5D HEALTH STATUS IN PSORIATIC ARTHRITIS PATIENTS WITH OR WITHOUT AXIAL DISEASE: RESULTS OF SUBANALYSIS OF THE PATERA STUDY

2. AB0141 THE DYNAMICAL TRAJECTORY OF GLUCOCORTICOIDS TAPERING AND DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS COMMENCING GLUCOCORTICOIDS WITH CSDMARDS: A REAL-WORLD DATA FROM 2009 TO 2020

3. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

4. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

5. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China;Lupus;2024-02-05

2. COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases;Vaccines;2023-12-04

3. Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis;Joint Bone Spine;2022-10

4. Réponse sérologique après vaccination contre le coronavirus chez les patients atteints de rhumatisme inflammatoire chronique traités par DMARDs : étude de cohorte et revue systématique avec méta-analyse;Revue du Rhumatisme;2022-10

5. Immunogenicity and Safety of SARS-CoV-2 Vaccination in Patients With Rheumatic Diseases: A Systematic Review and Meta-analysis;JCR: Journal of Clinical Rheumatology;2022-06-08